BRD4: An emerging prospective therapeutic target in glioma
Despite advances in treatment, the prognosis for glioma patients remains poor. Bromodomain-containing protein 4 (BRD4), a member of the bromodomain and extraterminal (BET) protein family, plays an important role in controlling oncogene expression and genome stability. In recent years, numerous BRD4...
Bewaard in:
| Hoofdauteurs: | , , , , |
|---|---|
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2021-06-01
|
| Reeks: | Molecular Therapy: Oncolytics |
| Onderwerpen: | |
| Online toegang: | http://www.sciencedirect.com/science/article/pii/S2372770521000371 |
| Tags: |
Geen labels, Wees de eerste die dit record labelt!
|